Crosstalk between the B7/CD28 and EGFR pathways: Mechanisms and therapeutic opportunities
Author:
Funder
Cancer Research Institute
National Institutes of Health
U.S. Department of Defense
Publisher
Elsevier BV
Subject
Cell Biology,Genetics(clinical),Molecular Biology,Biochemistry
Reference158 articles.
1. The epidermal growth factor receptor family;Bazley;Endocr Relat Canc,2005
2. Treatment of non-small-cell lung cancer with erlotinib or gefitinib;Cataldo;N Engl J Med,2011
3. ERBB receptors: from oncogene discovery to basic science to mechanism-based cancer therapeutics;Arteaga;Canc Cell,2014
4. EGFR antagonists in cancer treatment;Ciardiello;N Engl J Med,2008
5. The quest to overcome resistance to EGFR-targeted therapies in cancer;Chong;Nat Med,2013
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Human endogenous retrovirus-H long terminal repeat-associating 2: an emerging immune checkpoint for cancer immunotherapy;Journal of Leukocyte Biology;2024-07-08
2. Single-cell transcriptomic sequencing data reveal aberrant DNA methylation in SMAD3 promoter region in tumor-associated fibroblasts affecting molecular mechanism of radiosensitivity in non-small cell lung cancer;Journal of Translational Medicine;2024-03-16
3. T cell senescence: a new perspective on immunotherapy in lung cancer;Frontiers in Immunology;2024-02-13
4. B7-H3 regulates anti-tumor immunity and promotes tumor development in colorectal cancer;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-01
5. Dual Inhibition of B7-H3 and EGFR Overcomes Acquired Chemoresistance in Colon Adenocarcinoma;Journal of Cancer;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3